Related Experiment Videos
Evolving therapeutic paradigms for HIV and HCV
Akhteruzzaman Molla1, William Kohlbrenner
1Antiviral Research, Global Pharmaceuticals Research & Development, Abbott Laboratories, Department R47D, Building AP52N, 200 Abbott Park Road, Abbott Park, IL 60064-6217, USA. akhter.m.molla@abbott.com
Current Opinion in Biotechnology
|December 10, 2003
Summary
Advancing molecular technologies enhances understanding of viral replication for human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Further research is needed to overcome challenges and develop next-generation antiviral drugs.
Area of Science:
- Molecular biology
- Virology
- Drug discovery
Background:
- Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) remain significant global health challenges.
- Current therapeutic agents have limitations, necessitating the development of improved treatments.
Purpose of the Study:
- To highlight the role of molecular technologies in advancing the understanding of viral replication.
- To discuss the development of next-generation therapeutics for HIV and HCV.
Main Methods:
- Review of current molecular technologies for studying viral replication.
- Analysis of existing therapeutic strategies and their limitations.
- Identification of technical and therapeutic challenges in antiviral drug development.
Main Results:
- Molecular technologies offer enhanced insights into viral replication mechanisms.
- Progress has been made in developing new therapeutic approaches for HIV and HCV.
- Significant technical and therapeutic hurdles impede further treatment advancements.
Conclusions:
- Continued development of molecular technologies is crucial for understanding viral infections.
- Addressing key challenges is essential for the next generation of effective HIV and HCV drugs.